GlassScriptPhysician profile
Kerry C Lanigan
NPI 1801186481
$1,607.57
in general payments reported to CMS, 2019-2025
8 companies · $205 in 2025
The $205 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $21.00 · 2020: $42.74 · 2021: $492 · 2022: $455 · 2023: $134 · 2024: $258 · 2025: $205.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $596.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $596.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $961.17 | 2020-2024 | Xarelto |
| Abbvie INC. | $279.41 | 2023-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $195.22 | 2024-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $100.80 | 2019-2021 | |
| Pfizer INC. | $28.32 | 2021-2022 | |
| Shionogi INC | $15.60 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.65 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $12.40 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kerry Lanigan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.